Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diagnosis, Computer-Assisted | 2 | 2017 | 95 | 1.000 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2017 | 157 | 0.950 |
Why?
|
Heart Defects, Congenital | 5 | 2025 | 1827 | 0.940 |
Why?
|
Fontan Procedure | 2 | 2023 | 182 | 0.750 |
Why?
|
Scimitar Syndrome | 1 | 2022 | 52 | 0.740 |
Why?
|
Mass Screening | 2 | 2017 | 786 | 0.700 |
Why?
|
Prenatal Diagnosis | 2 | 2025 | 600 | 0.690 |
Why?
|
Pulmonary Veins | 1 | 2022 | 161 | 0.690 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 75 | 0.650 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 872 | 0.550 |
Why?
|
Athletes | 1 | 2017 | 66 | 0.520 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 259 | 0.450 |
Why?
|
Electroencephalography | 1 | 2016 | 866 | 0.370 |
Why?
|
Electrocardiography | 1 | 2017 | 978 | 0.370 |
Why?
|
Algorithms | 1 | 2017 | 1630 | 0.330 |
Why?
|
Echocardiography | 4 | 2025 | 1057 | 0.330 |
Why?
|
Endocardial Fibroelastosis | 1 | 2023 | 11 | 0.210 |
Why?
|
Palivizumab | 1 | 2023 | 47 | 0.210 |
Why?
|
Atrioventricular Block | 1 | 2023 | 38 | 0.200 |
Why?
|
Reproducibility of Results | 2 | 2022 | 2894 | 0.200 |
Why?
|
Pregnancy | 4 | 2025 | 7223 | 0.200 |
Why?
|
Infant, Newborn | 4 | 2025 | 8240 | 0.190 |
Why?
|
Retrospective Studies | 5 | 2025 | 16389 | 0.180 |
Why?
|
Guideline Adherence | 1 | 2023 | 378 | 0.170 |
Why?
|
Ventricular Function | 1 | 2020 | 91 | 0.160 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 345 | 0.160 |
Why?
|
Ventricular Function, Right | 1 | 2020 | 112 | 0.160 |
Why?
|
Ultrasonography, Prenatal | 1 | 2025 | 972 | 0.160 |
Why?
|
Female | 8 | 2025 | 66885 | 0.150 |
Why?
|
Infant | 3 | 2023 | 12518 | 0.150 |
Why?
|
Antiviral Agents | 1 | 2023 | 767 | 0.140 |
Why?
|
Quality Improvement | 1 | 2023 | 646 | 0.140 |
Why?
|
Cohort Studies | 2 | 2017 | 4824 | 0.140 |
Why?
|
Child | 4 | 2023 | 24436 | 0.130 |
Why?
|
Cardiac Surgical Procedures | 1 | 2025 | 1121 | 0.130 |
Why?
|
United States | 3 | 2025 | 10936 | 0.130 |
Why?
|
Logistic Models | 1 | 2020 | 1815 | 0.120 |
Why?
|
Heart Ventricles | 1 | 2020 | 772 | 0.120 |
Why?
|
Male | 6 | 2025 | 61663 | 0.120 |
Why?
|
Health Services Accessibility | 1 | 2020 | 608 | 0.120 |
Why?
|
Humans | 9 | 2025 | 125392 | 0.110 |
Why?
|
Pilot Projects | 1 | 2017 | 1397 | 0.100 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 2058 | 0.090 |
Why?
|
Incidence | 1 | 2017 | 3154 | 0.080 |
Why?
|
Adolescent | 2 | 2017 | 19373 | 0.080 |
Why?
|
Risk Factors | 1 | 2020 | 10331 | 0.060 |
Why?
|
Triage | 1 | 2025 | 139 | 0.060 |
Why?
|
Thoracic Surgery | 1 | 2025 | 161 | 0.050 |
Why?
|
Young Adult | 1 | 2017 | 9069 | 0.050 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2023 | 144 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 240 | 0.050 |
Why?
|
Societies, Medical | 1 | 2025 | 698 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2025 | 435 | 0.040 |
Why?
|
Adult | 1 | 2020 | 29692 | 0.040 |
Why?
|
Fetus | 1 | 2023 | 585 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2023 | 443 | 0.040 |
Why?
|
Patient Discharge | 1 | 2023 | 496 | 0.040 |
Why?
|
Hemodynamics | 1 | 2023 | 853 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2023 | 1273 | 0.030 |
Why?
|
Hospitalization | 1 | 2023 | 1790 | 0.030 |
Why?
|